Doshi, P., Spence, O., Kuzucan, A., & Powers, J. H. (2019). Communication of Nonefficacy Benefits of New Drugs Approved on the Basis of Noninferiority Trials Alone: Cohort Study of FDA and Sponsor Communication, 2011-2017. JAMA Intern Med.
Citación estilo ChicagoDoshi, Peter, O’Mareen Spence, Aida Kuzucan, and John H. Powers. "Communication of Nonefficacy Benefits of New Drugs Approved On the Basis of Noninferiority Trials Alone: Cohort Study of FDA and Sponsor Communication, 2011-2017." JAMA Intern Med 2019.
Cita MLADoshi, Peter, O’Mareen Spence, Aida Kuzucan, and John H. Powers. "Communication of Nonefficacy Benefits of New Drugs Approved On the Basis of Noninferiority Trials Alone: Cohort Study of FDA and Sponsor Communication, 2011-2017." JAMA Intern Med 2019.